TF Market Research



Title:

DOPAMINERGIC PIPELINE ANALYSIS - DOPAMINERGIC ANTIPYSCHOTICS

Price:$400.00
Publication Date:Feb 23, 2004
Source:DATAMONITOR PHARMACEUTICAL INTELLIGENCE - REPORTS
Brief Excerpt:...Table # shows the dopaminergic antipsychotics currently marketed and considered as potential gold-standard therapies. ...
Length:5 Pages
Geographic Region:INTERNATIONAL
Industries:HEALTH CARE, MEDICAL SUPPLY, PHARMACEUTICALS
Format:Adobe Acrobat Adobe Acrobat

Sections
TitleStarting PageNumber of Pages
Antipsychotics Drugs: Dopaminergic Pipeline Analysis11
CHAPTER 1 DOPAMINERGIC ANTIPSYCHOTICS11
1.1 Pipeline overview11
1.2 Definition of gold standard21
1.3 Abilify (aripiprazole)21
Efficacy31
Side-effect profile31
Compliance31
Marketing factors32
1.4 Drug analysis41
PNU-17041341
Drug overview41
Clinical trial data42
Datamonitor comment51
Tables
TitleStarting PageNumber of Pages
Late-stage dopamine antagonists, 200311
Marketed antipsychotics considered for dopaminergic gold standard, 200321

Enter the keyword(s) which you would like to search for within this document and click "Search"

 
Purchase Report
Price: $400.00

Looking For Something Else?





TF Market Research

TF Market Research® reports contain in-depth primary research and statistics, market trends, forecasts, segment analysis and much more from over 100 top consulting, market research and business publishing sources. The service is updated daily.

  about us | contact us | public company index | private company index | pcan | widget | your privacy rights | terms & conditions  

Copyright © 2008 Alacra, Inc., 100 Broadway, Suite 1100, New York, NY 10005. All rights reserved.
Reproduction in whole or in part in any form or medium without express written permission is prohibited.